Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Bavarian Nordic sells PRV for $95mm

Executive Summary

Bavarian Nordic AS sold an undisclosed company a Priority Review Voucher (PRV) for $95mm. Bavarian Nordic got the PRV in September 2019 upon FDA approval of Jynneos (MVA-BN) for prevention of smallpox and monkeypox.
Deal Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
    • Large Molecule
  • Pharmaceuticals
    • Drug Delivery
      • Macromolecule
    • Vaccines
Deal Status
  • Final
Deal Type
  • Financing
    • Other

Related Companies